1. Home
  2. LIXT vs NSYS Comparison

LIXT vs NSYS Comparison

Compare LIXT & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$5.35

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Logo Nortech Systems Incorporated

NSYS

Nortech Systems Incorporated

HOLD

Current Price

$12.25

Market Cap

25.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
NSYS
Founded
2005
1981
Country
United States
United States
Employees
3
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
25.6M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
LIXT
NSYS
Price
$5.35
$12.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
63.5K
15.7K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.85
EPS
N/A
N/A
Revenue
N/A
$14,371,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.01
52 Week Low
$0.64
$6.50
52 Week High
$6.09
$15.39

Technical Indicators

Market Signals
Indicator
LIXT
NSYS
Relative Strength Index (RSI) 67.95 43.69
Support Level $3.77 $8.62
Resistance Level $6.03 $15.11
Average True Range (ATR) 0.63 0.96
MACD 0.05 -0.26
Stochastic Oscillator 82.72 28.26

Price Performance

Historical Comparison
LIXT
NSYS

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

Share on Social Networks: